article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. years after TAVR and 4.9 years after TAVR and 4.9

article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

As cardiothoracic surgery continues to evolve, STS has responded by adding new risk models to guide treatment decisions and benchmark performance,” said STS President Jennifer C. SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. and 3.8%, respectively.

TAVR 111
article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

The conference, healthcare’s leading scientific and educational convening specializing in cardiothoracic surgery, has a rich history of showcasing clinical trials with a strong foundation of detailed methodology and trusted data collection governed by ethical clinical principles.

Research 111
article thumbnail

New Late-breaking Data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-effectiveness Benefits of TAVR Platform

DAIC

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52
article thumbnail

New Study Finds Mechanical Valves Offer Superior Long-Term Survival for Aortic Valve Replacement Patients Aged 60 and Younger

Society of Thoracic Surgeons - Congenital

The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement, said Michael Bowdish, MD, lead author of the study and a cardiothoracic surgeon at Cedars-Sinai Medical Center in Los Angeles.

article thumbnail

Comparing TAVR and SAVR in Medicare Beneficiaries with Aortic Stenosis and Coronary Artery Disease

Society of Thoracic Surgeons - Congenital

Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease. During the Top Adult Cardiac Surgery Abstracts session on Sunday, Jan.

article thumbnail

Surgical management of native aortic valve leaflet avulsion during TAVR

Journal of Cardiothoracic Surgery

Transcatheter aortic valve replacement (TAVR) has increased in utilization since its approval for management of aortic stenosis patients across all risk strata. We report a rare case of aortic valve leaflet av.